US Patent Issued on Nov. 3 for "Application of naringin combined with rapamycin in preparation of medications for treating hyperlipidemia" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,778,974, issued on Nov. 3.

"Application of naringin combined with rapamycin in preparation of medications for treating hyperlipidemia" was invented by Lina Niu (Xi'an, China), Kaiyan Wang (Xi'an, China), Weiwei Yu (Xi'an, China), Wen Qin (Xi'an, China), Yuxuan Ma (Xi'an, China) and Chen Lei (Xi'an, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to the field of medicine and specifically to an application of naringin combined with rapamycin in preparation of medications for treating hyperlipidemia. Naringin achieves anti-inflammatory and lipid-lowering effects by inhibiting the formation of oxLp-NLRP3 complexes. The pre...